This clinical-stage biotech develops therapies for NASH and obesity, advancing a pipeline of proprietary small-molecule drug ...
Novartis AG faces major patent expiries but is buying pipeline assets to sustain growth. Click for this NVS update.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results